Lab. Experimental Hematology, Dept. Clinical Biology, Jessa Hospital, Hasselt, Belgium.
Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium.
Nat Commun. 2021 Mar 25;12(1):1861. doi: 10.1038/s41467-021-22140-0.
Multiple myeloma (MM) is consistently preceded by precursor conditions recognized clinically as monoclonal gammopathy of undetermined significance (MGUS) or smoldering myeloma (SMM). We interrogate the whole genome sequence (WGS) profile of 18 MGUS and compare them with those from 14 SMMs and 80 MMs. We show that cases with a non-progressing, clinically stable myeloma precursor condition (n = 15) are characterized by later initiation in the patient's life and by the absence of myeloma defining genomic events including: chromothripsis, templated insertions, mutations in driver genes, aneuploidy, and canonical APOBEC mutational activity. This data provides evidence that WGS can be used to recognize two biologically and clinically distinct myeloma precursor entities that are either progressive or stable.
多发性骨髓瘤(MM)通常先于临床上被识别为单克隆丙种球蛋白病(MGUS)或冒烟型骨髓瘤(SMM)的前驱状态。我们研究了 18 例 MGUS 的全基因组序列(WGS)图谱,并将其与 14 例 SMM 和 80 例 MM 进行了比较。我们发现,15 例具有非进展性、临床稳定的骨髓瘤前驱状态的病例的特征是在患者生命中的较晚阶段开始,并且缺乏骨髓瘤定义性的基因组事件,包括:染色体重排、模板插入、驱动基因突变、非整倍体和典型的 APOBEC 突变活性。这些数据提供了证据,表明 WGS 可用于识别两种在生物学和临床上具有明显差异的骨髓瘤前驱实体,它们要么是进展性的,要么是稳定的。